Clinical trials: Microangiopathy, Thromboic

Thrombotic Thrombocytopenic Purpura (TTP), Immune Thrombotic Thrombocytopenic Purpura

Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center

• Recruiting
• Age: All ages
• Observational study

Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and ischemic organ damage due to microvascular thrombosis.

Conditions

Thrombotic Thrombocytopenic Purpura (TTP), Immune Thrombotic Thrombocytopenic Purpura, Thrombotic Microangiopathies, Microangiopathy, Thromboic

Trial name

TWILIGHT (NCT07205861)

Where

France

Volunteers

1,200 people

Sponsor

Assistance Publique - Hôpitaux de Paris